Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.04 USD | -2.11% |
|
-34.49% | 0.00% |
22/04 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
22/04 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |